Skip to main content
VCbacked
Log inGet Started

Ermium Therapeutics

Paris, France

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.

$6.3M raised
Jun 2022
Series A
BiotechnologyHealth CarePharmaceutical

Top Investors

Kurma PartnersEurazeoIdinvest PartnersKainova TherapeuticsFountain Healthcare Partners

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ermium Therapeutics

How much funding has Ermium Therapeutics raised?
Ermium Therapeutics has raised $6.3M in total funding. The most recent round was Series A. The last funding was announced in June 2022.
Who are Ermium Therapeutics's investors?
Ermium Therapeutics's investors include Kurma Partners, Eurazeo, Idinvest Partners, Kainova Therapeutics, Fountain Healthcare Partners.
Where is Ermium Therapeutics headquartered?
Ermium Therapeutics is headquartered in Paris, France.
What does Ermium Therapeutics do?
Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.
What stage is Ermium Therapeutics at?
Ermium Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ermium Therapeutics — Funding & Investors." VCBacked, June 30, 2022, https://www.vcbacked.co/company/ermium-therapeutics. Accessed July 4, 2026.
APA
VCBacked. (2022). Ermium Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/ermium-therapeutics
Wikipedia (cite web)
{{cite web |title=Ermium Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ermium-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K